NIH Office of Dietary Supplements (ODS)
US governmentOffice of Dietary Supplements, U.S. National Institutes of Health (NIH) · United States
Visit the source site · Audited 2026-10-14
Who pays for it
ODS reports a FY2024 budget of $28.5 million, including $20.4 million for research projects, with grant co-funding its largest allocation; direct industry contributions were not quantified.
Status: Labeled
ODS is a federal office, and industry representatives took part in planning. The audit found no evidence that industry funds or controls ODS content, so SafeMomma labels the source and checks claims against independent evidence.
How SafeMomma uses it
Cited for supplement and nutrient information with a visible U.S. government label, an update-date check, and independent corroboration.
The audit
- Who controls it
- ODS staff set initial priorities for its 2025–2029 plan, gathered scientific, government, outside, and industry input, and sent the final plan to NIH leadership for approval. A 2016–2017 account describes staff and outside expert review of fact sheets, but does not establish that the same process applies to every current page.
- Money
- ODS reports a FY2024 budget of $28.5 million and $20.4 million for research projects, with grant co-funding its largest allocation. It says it does not make research grants directly, and its materials do not quantify industry contributions or establish industry funding of ODS content.
- Conflict rules
- The pages reviewed describe expert and industry participation but do not give page-level financial disclosures for fact-sheet authors or reviewers. NIH grant-review conflict rules apply to grant reviewers, not as a substitute for fact-sheet disclosures.
- Method
- Fact sheets link references and explain findings in plain-language summaries. The 2016–2017 account describes literature review and multiple reviews, while the sampled vitamin D sheet reports mixed or null results and possible harms; no standard evidence-grading scale was visible.
- Dates on its pages
- Pages show update dates, but the sampled vitamin D consumer sheet was last updated November 8, 2022, and the three-year review target came from a 2016–2017 report, not a current guarantee.
- Political exposure
- ODS is within NIH, and its 2025–2029 plan went to NIH leadership for approval. NIH's unified strategy was updated July 2, 2026, and CRS reported on April 10, 2026 that 1,392 NIH awards totaling $539 million in unliquidated obligations had been terminated, many later reinstated; no evidence was found that an ODS consumer fact sheet was specifically removed or rewritten under political pressure.
- Money exposure
- Industry participation in planning is documented. In an August 30, 2024 comment letter, the Council for Responsible Nutrition proposed partnerships, an industry advisory council, and related actions; those were CRN proposals, not evidence that ODS adopted them or that CRN funds or controls ODS content.
- Track record
- ODS was not specifically assessed in the five backtests, so no source-specific track-record finding is reported here.
Where this comes from
Incentive exposure describes pressure from money or politics, not whether the source is right. Funding alone does not show influence.